Andreas Hald

1.4k total citations
23 papers, 1.1k citations indexed

About

Andreas Hald is a scholar working on Cancer Research, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Andreas Hald has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Oncology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Andreas Hald's work include Protease and Inhibitor Mechanisms (8 papers), Pain Mechanisms and Treatments (5 papers) and Bone health and treatments (3 papers). Andreas Hald is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Pain Mechanisms and Treatments (5 papers) and Bone health and treatments (3 papers). Andreas Hald collaborates with scholars based in Denmark, United States and Sweden. Andreas Hald's co-authors include Julie Lotharius, Ming Ding, Misaki Matsumoto, Makoto Inoue, Hiroshi Ueda, Anne‐Marie Heegaard, R Hansen, Weijiao Xie, Signe Nedergaard and Birgitte Rønø and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Developmental Biology.

In The Last Decade

Andreas Hald

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Hald Denmark 18 399 294 266 232 165 23 1.1k
Martin J. Stevens United States 18 624 1.6× 345 1.2× 125 0.5× 267 1.2× 120 0.7× 23 1.8k
C Zoia Italy 19 269 0.7× 364 1.2× 298 1.1× 127 0.5× 241 1.5× 36 1.1k
Judyta K. Juranek Poland 17 306 0.8× 321 1.1× 128 0.5× 269 1.2× 199 1.2× 43 1.1k
Xin Luo United States 21 794 2.0× 464 1.6× 411 1.5× 74 0.3× 195 1.2× 41 1.7k
Tahar Aboulkassim Canada 18 320 0.8× 450 1.5× 168 0.6× 81 0.3× 200 1.2× 27 1.1k
Zhenzhong Li China 20 296 0.7× 406 1.4× 367 1.4× 95 0.4× 120 0.7× 72 1.1k
George T. Kannarkat United States 17 318 0.8× 303 1.0× 283 1.1× 536 2.3× 450 2.7× 25 1.3k
Chandani Limbad United States 12 439 1.1× 470 1.6× 188 0.7× 89 0.4× 197 1.2× 14 1.3k
Annamaria Confaloni Italy 21 480 1.2× 665 2.3× 161 0.6× 239 1.0× 173 1.0× 59 1.4k
Chun‐Yi Jiang China 21 395 1.0× 684 2.3× 277 1.0× 157 0.7× 304 1.8× 42 1.4k

Countries citing papers authored by Andreas Hald

Since Specialization
Citations

This map shows the geographic impact of Andreas Hald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hald more than expected).

Fields of papers citing papers by Andreas Hald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hald. The network helps show where Andreas Hald may publish in the future.

Co-authorship network of co-authors of Andreas Hald

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hald. A scholar is included among the top collaborators of Andreas Hald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hald. Andreas Hald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Tengpeng, Thorbjørn Krejsgaard, Claudia Nastasi, et al.. (2019). Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis. Dermatology. 236(2). 123–132. 3 indexed citations
2.
Erlendsson, Andrés M., Daniel Thaysen‐Petersen, Christiane Bay, et al.. (2016). Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice. PLoS ONE. 11(9). e0162597–e0162597. 6 indexed citations
3.
Emmert, Steffen, Holger A. Haenssle, John R. Zibert, et al.. (2016). Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate. PLoS ONE. 11(9). e0160096–e0160096. 18 indexed citations
4.
Litman, Thomas, Andreas Hald, Hanne Norsgaard, et al.. (2016). Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Experimental Dermatology. 25(6). 453–459. 62 indexed citations
5.
Rønø, Birgitte, Lars H. Engelholm, Leif R. Lund, & Andreas Hald. (2013). Gender Affects Skin Wound Healing in Plasminogen Deficient Mice. PLoS ONE. 8(3). e59942–e59942. 22 indexed citations
6.
Madsen, Daniel H., Henrik J. Jürgensen, Signe Ingvarsen, et al.. (2013). Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis. PLoS ONE. 8(8). e71261–e71261. 27 indexed citations
7.
Madsen, Daniel H., Henrik J. Jürgensen, Signe Ingvarsen, et al.. (2012). Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis. The Journal of Pathology. 227(1). 94–105. 44 indexed citations
8.
Hald, Andreas, Kristoffer L. Egerod, Lars H. Engelholm, et al.. (2012). Plasmin‐driven fibrinolysis facilitates skin tumor growth in a gender‐dependent manner. The FASEB Journal. 26(11). 4445–4457. 6 indexed citations
9.
Hald, Andreas, Birgitte Rønø, Leif R. Lund, & Kristoffer L. Egerod. (2012). LPS Counter Regulates RNA Expression of Extracellular Proteases and Their Inhibitors in Murine Macrophages. Mediators of Inflammation. 2012. 1–9. 19 indexed citations
10.
Lund, Ida Katrine, Boye Schnack Nielsen, Kasper Almholt, et al.. (2011). Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. Developmental Biology. 358(1). 56–67. 17 indexed citations
11.
Frøssing, Signe, Birgitte Rønø, Andreas Hald, John Rømer, & Leif R. Lund. (2010). Skin wound healing in MMP2‐deficient and MMP2 / Plasminogen double‐deficient mice. Experimental Dermatology. 19(8). e234–40. 26 indexed citations
12.
Hald, Andreas. (2009). Spinal Astrogliosis in Pain Models: Cause and Effects. Cellular and Molecular Neurobiology. 29(5). 609–619. 31 indexed citations
13.
Hald, Andreas, R Hansen, Ming Ding, et al.. (2009). Cancer‐induced bone loss and associated pain‐related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE‐10790. International Journal of Cancer. 125(5). 1177–1185. 18 indexed citations
14.
Hald, Andreas, Signe Nedergaard, R Hansen, Ming Ding, & Anne‐Marie Heegaard. (2008). Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. European Journal of Pain. 13(2). 138–145. 125 indexed citations
15.
Hald, Andreas, Ming Ding, Kristoffer L. Egerod, et al.. (2008). Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Pharmacology Biochemistry and Behavior. 91(1). 38–46. 31 indexed citations
16.
Hald, Andreas, Johan van Beek, & Julie Lotharius. (2007). Inflammation in parkinson’s disease. Sub-cellular biochemistry. 42. 249–279. 30 indexed citations
17.
Matsumoto, Misaki, Makoto Inoue, Andreas Hald, Weijiao Xie, & Hiroshi Ueda. (2006). Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin. Journal of Pharmacology and Experimental Therapeutics. 318(2). 735–740. 124 indexed citations
18.
Hald, Andreas, R Hansen, Ming Ding, et al.. (2006). Anti-nociceptive effects of the bisphosphonate risedronate in a syngeneic mouse model of bone cancer pain. Bone. 38(3). 51–51. 1 indexed citations
20.
Hald, Andreas & Julie Lotharius. (2005). Oxidative stress and inflammation in Parkinson's disease: is there a causal link?. Experimental Neurology. 193(2). 279–290. 411 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026